Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Advanced brain arteriovenous malformation embolization techniques
- Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model
- Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model
- An injectable shear-thinning biomaterial for endovascular embolization
- Application of a Novel Brain Arteriovenous Malformation Endovascular Grading Scale for Transarterial Embolization
- Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature
- Safety and Clinical Efficacy of Onyx for Embolization of Extracranial Head and Neck Vascular Anomalies
- The Use of Onyx for Embolization of Central Nervous System Arteriovenous Lesions in Pediatric Patients
- Brain Aneurysms and Arteriovenous Malformations: Advancements and Emerging Treatments in Endovascular Embolization
- Cerebral Aneurysm Multicenter European Onyx (CAMEO) Trial: Results of a Prospective Observational Study in 20 European Centers
- CT and MR Imaging Findings and Their Implications in the Follow-up of Patients with Intracranial Aneurysms Treated with Endosaccular Occlusion with Onyx
- A Reexamination of the Angiotoxicity of Superselective Injection of DMSO in the Swine Rete Embolization Model